Nurit P. Azouz
YOU?
Author Swipe
View article: The Bordetella type III secretion system effector BteA targets host eosinophil-epithelial signaling to promote IL-1Ra expression and persistence
The Bordetella type III secretion system effector BteA targets host eosinophil-epithelial signaling to promote IL-1Ra expression and persistence Open
View article: Differential effects of proton pump inhibitors on the aryl hydrocarbon receptor in esophageal epithelial cells
Differential effects of proton pump inhibitors on the aryl hydrocarbon receptor in esophageal epithelial cells Open
View article: Aryl hydrocarbon receptor and IL-13 signaling crosstalk in human keratinocytes and atopic dermatitis
Aryl hydrocarbon receptor and IL-13 signaling crosstalk in human keratinocytes and atopic dermatitis Open
Introduction Atopic dermatitis (AD) is an allergic skin disease mediated by skin barrier impairment and IL-13-driven immune response. Activation of the aryl hydrocarbon receptor (AHR) has shown promise in early clinical trials for AD; howe…
View article: Aryl hydrocarbon receptor (AHR) and IL-13 signaling crosstalk in human keratinocytes and atopic dermatitis
Aryl hydrocarbon receptor (AHR) and IL-13 signaling crosstalk in human keratinocytes and atopic dermatitis Open
Atopic dermatitis (AD) is an allergic skin disease mediated by skin barrier impairment and IL-13-driven immune response. Activation of the aryl hydrocarbon receptor (AHR) has shown promise in early clinical trials for AD, however, the mech…
View article: Aryl Hydrocarbon Receptor Suppresses Eosinophilic Esophagitis Responses through OVOL1 and SPINK7
Aryl Hydrocarbon Receptor Suppresses Eosinophilic Esophagitis Responses through OVOL1 and SPINK7 Open
Eosinophilic esophagitis (EoE) is a type 2 allergic disease characterized by esophageal inflammation and epithelial cell dysfunction. Acquired loss of the anti-serine protease of kazal type 7 (SPINK7) in the squamous epithelium of the esop…
View article: A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells Open
Significance MM3122 represents an advanced lead candidate for clinical development as a novel antiviral drug for COVID-19. In addition to being novel drugs, these selective TMRSS2 inhibitors can be used as valuable chemical probes to help …
View article: Achieving Precision Medicine in Allergic Disease: Progress and Challenges
Achieving Precision Medicine in Allergic Disease: Progress and Challenges Open
Allergic diseases (atopic dermatitis, food allergy, eosinophilic esophagitis, asthma and allergic rhinitis), perhaps more than many other traditionally grouped disorders, share several overlapping inflammatory pathways and risk factors, th…
View article: A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells Open
The host cell serine protease TMPRSS2 is an attractive therapeutic target for COVID-19 drug discovery. This protease activates the Spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and of other coronaviruses and…
View article: Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2 Open
Background: Host proteases have been suggested to be crucial for dissemination of MERS, SARS-CoV, and SARS-CoV-2 coronaviruses, but the relative contribution of membrane versus intracellular proteases remains controversial. Transmembrane s…
View article: Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat
Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat Open
The authors unravel the molecular action principle of nafamostat and camostat, two potential COVID-19 drugs targeting the human protein TMPRSS2.
View article: Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors
Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors Open
View article: Molecular mechanism of SARS-CoV-2 cell entry inhibition via TMPRSS2 by Camostat and Nafamostat mesylate
Molecular mechanism of SARS-CoV-2 cell entry inhibition via TMPRSS2 by Camostat and Nafamostat mesylate Open
The entry of the coronavirus SARS-CoV-2 into human cells can be inhibited by the approved drugs camostat and nafamostat. Here we elucidate the molecular mechanism of these drugs by combining experiments and simulations. In vitro assays con…
View article: Uncovering the secretes of allergic inflammation
Uncovering the secretes of allergic inflammation Open
Allergic asthma is a chronic inflammatory lung disease associated with increased cytokine secretion. Aspects of airway inflammation are also linked to a common genetic variant that corresponds to the small GTPase, Rab27, a protein involved…
View article: Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis
Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis Open
Eosinophilic esophagitis is mediated by uncontrolled proteolytic activity of kallikrein 5 influencing the epithelial barrier and innate immunity.
View article: Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2 Open
Host proteases have been suggested to be crucial for dissemination of MERS, SARS-CoV, and SARS-CoV-2 coronaviruses, but the relative contribution of membrane versus intracellular proteases remains controversial. Transmembrane serine protea…
View article: A key role for IL-13 signaling via the type 2 IL-4 receptor in atopic dermatitis
A key role for IL-13 signaling via the type 2 IL-4 receptor in atopic dermatitis Open
View article: Mechanisms of gastrointestinal allergic disorders
Mechanisms of gastrointestinal allergic disorders Open
Gastrointestinal (GI) allergic disease is an umbrella term used to describe a variety of adverse, food antigen-driven, immune-mediated diseases. Although these diseases vary mechanistically, common elements include a breakdown of immunolog…
View article: Epithelial origin of eosinophilic esophagitis
Epithelial origin of eosinophilic esophagitis Open
View article: The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses
The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses Open
Loss of esophageal SPINK7 unleashes protease activity, impairs barrier function, and induces proinflammatory responses.
View article: The Anti-protease SPINK7 is a Checkpoint Regulator of Esophageal Epithelial Inflammatory Responses
The Anti-protease SPINK7 is a Checkpoint Regulator of Esophageal Epithelial Inflammatory Responses Open
View article: Rab5 is critical for SNAP23 regulated granule-granule fusion during compound exocytosis
Rab5 is critical for SNAP23 regulated granule-granule fusion during compound exocytosis Open
View article: Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis
Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis Open
View article: LRRC31 is induced by IL-13 and regulates kallikrein expression and barrier function in the esophageal epithelium
LRRC31 is induced by IL-13 and regulates kallikrein expression and barrier function in the esophageal epithelium Open
View article: Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis Open
Mast Cells (MC) are secretory cells of the immune system that accomplish their physiological and pathological functions by releasing pre-formed and newly synthesized allergic, inflammatory and immunoregulatory mediators. MCs' mediators aff…